What should you know about tumour debulking for ovarian cancer?

Debulking, also called cytoreductive surgery, is used when ovarian cancer involves more than the ovary or when removing visible deposits may help the overall plan. The operation can involve the ovaries, fallopian tubes, uterus, fatty tissue in the abdomen or other affected areas. The exact procedures depend on where disease is found and what can be removed safely.

Some people have surgery before chemotherapy, while others receive medicine first and surgery afterwards. The team considers scans, examination findings, symptoms, nutrition, other illnesses and the likely effect on daily function. The aim is not to promise that every cancer cell will be removed; microscopic disease may still require systemic treatment.

Ask the gynaecological oncology team what they expect to remove, whether an oophorectomy is planned, and whether bowel or urinary surgery might be needed. Discuss recovery, fertility, hormonal effects, a possible stoma, pain control and how treatment timing may change. Imaging such as pelvic ultrasound may contribute to assessment, while genomic tumour profiling can help guide later treatment choices.

Before surgery, share your medicines, allergies, previous operations, nutrition concerns and support needs. Afterward, follow wound, movement, eating and bowel instructions. Chemotherapy may be recommended before or after surgery; palliative care can also support symptoms and wellbeing at any stage.

After surgery, contact the team for fever, worsening wound redness, drainage, uncontrolled pain, repeated vomiting, inability to pass urine or stool, or increasing abdominal swelling. Seek urgent help for severe breathlessness, chest pain, fainting, heavy bleeding or sudden confusion. Before treatment, urgent review is also needed for severe pain, persistent vomiting or inability to keep fluids down.

What is the purpose of debulking in my case? Which organs or tissues might be involved? Would chemotherapy come before or after surgery? What recovery support will I need at home? How will pathology and genomic results affect the next decision?